JP Morgan Maintains Neutral on Chemours, Lowers Price Target to $26
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Jeffrey Zekauskas has maintained a Neutral rating on Chemours (NYSE:CC) and lowered the price target from $38 to $26.
November 07, 2023 | 8:09 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
JP Morgan has maintained a Neutral rating on Chemours but lowered the price target from $38 to $26.
The lowering of the price target by JP Morgan indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on Chemours' stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100